FDA Inspection 1223634 — Cooper Institute for Advanced Reproductive Medicine
The FDA completed an inspection of Cooper Institute for Advanced Reproductive Medicine on November 16, 2023 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 16, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houston, TX (United States)